The Early TAVR study demonstrated that nonsurgical transcatheter heart valve replacement significantly improves outcomes for patients with severe aortic stenosis, compared to standard care.
It's long been known that severe aortic stenosis is associated with a worse prognosis with increased mortality. Usually within about two years, if the valve is not replaced, about half of patients will die.
Asymptomatic patients with severe aortic stenosis have traditionally been advised to wait with follow-ups, but new studies show the effectiveness of early nonsurgical interventions.
More than 13 percent of Americans over the age of 75 will develop aortic stenosis, a condition leading to restricted blood flow due to valve narrowing.
#transcatheter-heart-valve-replacement #aortic-stenosis #clinical-trials #cardiology #patient-outcomes
Collection
[
|
...
]